Erschienen in:
05.06.2023 | Editorial
The future of rare autonomic disease research
verfasst von:
Casey M. Rand, Debra E. Weese-Mayer
Erschienen in:
Clinical Autonomic Research
|
Ausgabe 3/2023
Einloggen, um Zugang zu erhalten
Excerpt
There are more than 10,000 known rare diseases, defined as affecting < 200,000 people in the US or fewer than 1 in 2000 in the EU, collectively affecting ~ 350 million people worldwide [
1]. According to the U.S. Food & Drug Administration, less than 10% of these rare diseases currently have an approved treatment or therapy [
2]. Most rare diseases also lack diagnostic biomarkers, leading to often extended diagnostic journeys for patients and families [
3]. Taken together, hundreds of millions of people are still living with rare conditions lacking treatment or biomarkers. Without an understanding of what causes a specific rare disease, and a consistent biomarker to diagnose and follow the clinical course, the outlook for treatment is often bleak. …